Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Pediatric Nephrology
Erschienen in: Pediatric Nephrology 11/2014

01.11.2014 | Review

The interplay between drugs and the kidney in premature neonates

verfasst von: Michiel F Schreuder, Ruud R G Bueters, Karel Allegaert

Erschienen in: Pediatric Nephrology | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

The kidney plays a central role in the clearance of drugs. However, renal drug handling entails more than glomerular filtration and includes tubular excretion and reabsorption, and intracellular metabolization by cellular enzyme systems, such as the Cytochrome P450 isoenzymes. All these processes show maturation from birth onwards, which is one of the reasons why drug dosing in children is not simply similar to dosing in small adults. As kidney development normally finishes around the 36th week of gestation, being born prematurely will result in even more immature renal drug handling. Environmental effects, such as extra-uterine growth restriction, sepsis, asphyxia, or drug treatments like caffeine, aminoglycosides, or non-steroidal anti-inflammatory drugs, may further hamper drug handling in the kidney. Dosing in preterm neonates is therefore dependent on many factors that need to be taken into account. Drug treatment may significantly hamper postnatal kidney development in preterm neonates, just like renal immaturity has an impact on drug handling. The restricted kidney development results in a lower number of nephrons that may have several long-term sequelae, such as hypertension, albuminuria, and renal failure. This review focuses on the interplay between drugs and the kidney in premature neonates.
Literatur
1.
Chen N, Aleksa K, Woodland C, Rieder M, Koren G (2006) Ontogeny of drug elimination by the human kidney. Pediatr Nephrol 21:160–168PubMedCrossRef
2.
Alcorn J, McNamara PJ (2002) Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. Clin Pharmacokinet 41:959–998PubMedCrossRef
3.
van den Anker JN, Schwab M, Kearns GL (2011) Developmental pharmacokinetics. Handb Exp Pharmacol 205:51–75PubMedCrossRef
4.
Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L (2006) Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 21:931–938PubMedCrossRef
5.
Ashley C, Currie A (2009) The renal drug handbook. Radcliffe, Oxford
6.
De Gregori S, De Gregori M, Ranzani GN, Borghesi A, Regazzi M, Stronati M (2009) Drug transporters and renal drug disposition in the newborn. J Matern Fetal Neonatal Med 22(Suppl 3):31–37PubMedCrossRef
7.
Burckhardt G (2012) Drug transport by organic anion transporters (OATs). Pharmacol Ther 136:106–130PubMedCrossRef
8.
Marques-Minana MR, Saadeddin A, Peris JE (2010) Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline. Br J Clin Pharmacol 70:713–720PubMedCrossRefPubMedCentral
9.
Urakami Y, Kimura N, Okuda M, Inui K (2004) Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney. Pharm Res 21:976–981PubMedCrossRef
10.
Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832–1843PubMedCrossRef
11.
Delanaye P, Mariat C, Cavalier E, Maillard N, Krzesinski JM, White CA (2011) Trimethoprim, creatinine and creatinine-based equations. Nephron Clin Pract 119:c187–193, discussion c193-184PubMedCrossRef
12.
Aleksa K, Matsell D, Krausz K, Gelboin H, Ito S, Koren G (2005) Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity. Pediatr Nephrol 20:872–885PubMedCrossRef
13.
de Wildt SN, Kearns GL, Hop WC, Murry DJ, Abdel-Rahman SM, van den Anker JN (2001) Pharmacokinetics and metabolism of intravenous midazolam in preterm infants. Clin Pharmacol Ther 70:525–531PubMedCrossRef
14.
Johnson TN, Rostami-Hodjegan A, Goddard JM, Tanner MS, Tucker GT (2002) Contribution of midazolam and its 1-hydroxy metabolite to preoperative sedation in children: a pharmacokinetic-pharmacodynamic analysis. Br J Anaesth 89:428–437PubMedCrossRef
15.
de Wildt SN, Kearns GL, Murry DJ, Koren G, van den Anker JN (2010) Ontogeny of midazolam glucuronidation in preterm infants. Eur J Clin Pharmacol 66:165–170PubMedCrossRefPubMedCentral
16.
Anderson BJ, Larsson P (2011) A maturation model for midazolam clearance. Paediatr Anaesth 21:302–308PubMedCrossRef
17.
Allegaert K, Rochette A, Veyckemans F (2011) Developmental pharmacology of tramadol during infancy: ontogeny, pharmacogenetics and elimination clearance. Paediatr Anaesth 21:266–273PubMedCrossRef
18.
Quaggin SE, Kreidberg J (2008) Embryology of the kidney. In: Brenner BM (ed) Brenner and Rector’s the kidney. Saunders, Elsevier, Philadelphia, pp 3–24
19.
Faa G, Gerosa C, Fanni D, Monga G, Zaffanello M, Van Eyken P, Fanos V (2012) Morphogenesis and molecular mechanisms involved in human kidney development. J Cell Physiol 227:1257–1268PubMedCrossRef
20.
Bertram JF, Douglas-Denton RN, Diouf B, Hughson MD, Hoy WE (2011) Human nephron number: implications for health and disease. Pediatr Nephrol 26:1529–1533PubMedCrossRef
21.
22.
Brownfoot FC, Crowther CA, Middleton P (2008) Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev:CD006764
23.
Singh RR, Moritz KM, Bertram JF, Cullen-McEwen LA (2007) Effects of dexamethasone exposure on rat metanephric development: in vitro and in vivo studies. Am J Physiol Renal Physiol 293:F548–554PubMedCrossRef
24.
Seckl JR, Cleasby M, Nyirenda MJ (2000) Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Kidney Int 57:1412–1417PubMedCrossRef
25.
Guron G, Marcussen N, Nilsson A, Sundelin B, Friberg P (1999) Postnatal time frame for renal vulnerability to enalapril in rats. J Am Soc Nephrol 10:1550–1560PubMed
26.
27.
Abramovici A, Cantu J, Jenkins SM (2012) Tocolytic therapy for acute preterm labor. Obstet Gynecol Clin North Am 39:77–87PubMedCrossRef
28.
Kent AL, Maxwell LE, Koina ME, Falk MC, Willenborg D, Dahlstrom JE (2007) Renal glomeruli and tubular injury following indomethacin, ibuprofen, and gentamicin exposure in a neonatal rat model. Pediatr Res 62:307–312PubMedCrossRef
29.
Sutherland MR, Yoder BA, McCurnin D, Seidner S, Gubhaju L, Clyman RI, Black MJ (2012) Effects of ibuprofen treatment on the developing preterm baboon kidney. Am J Physiol Renal Physiol 302:F1286–1292PubMedCrossRefPubMedCentral
30.
Sutherland MR, Gubhaju L, Moore L, Kent AL, Dahlstrom JE, Horne RS, Hoy WE, Bertram JF, Black MJ (2011) Accelerated maturation and abnormal morphology in the preterm neonatal kidney. J Am Soc Nephrol 22:1365–1374PubMedCrossRefPubMedCentral
31.
Rodriguez MM, Gomez A, Abitbol C, Chandar J, Montane B, Zilleruelo G (2005) Comparative renal histomorphometry: a case study of oligonephropathy of prematurity. Pediatr Nephrol 20:945–949PubMedCrossRef
32.
Faa G, Gerosa C, Fanni D, Nemolato S, Locci A, Cabras T, Marinelli V, Puddu M, Zaffanello M, Monga G, Fanos V (2010) Marked interindividual variability in renal maturation of preterm infants: lessons from autopsy. J Matern Fetal Neonatal Med 23(Suppl 3):129–133PubMedCrossRef
33.
De Curtis M, Rigo J (2004) Extrauterine growth restriction in very-low-birthweight infants. Acta Paediatr 93:1563–1568PubMedCrossRef
34.
Schreuder MF, Nyengaard JR, Remmers F, van Wijk JA, D-vdW HA (2006) Postnatal food restriction in the rat as a model for a low nephron endowment. Am J Physiol Renal Physiol 291:F1104–F1107PubMedCrossRef
35.
Sutherland MR, O’Reilly M, Kenna K, Ong K, Harding R, Sozo F, Black MJ (2013) Neonatal hyperoxia: effects on nephrogenesis and long-term glomerular structure. Am J Physiol Renal Physiol 304:F1308–1316PubMedCrossRef
36.
Tolba AM, Hewedy FM, al-Senaidy AM, al-Othman AA (1998) Neonates’ vitamin A status in relation to birth weight, gestational age, and sex. J Trop Pediatr 44:174–177PubMedCrossRef
37.
Darlow BA, Graham PJ (2011) Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev:CD000501
38.
Kandasamy Y, Smith R, Wright IM, Lumbers ER (2013) Extra-uterine renal growth in preterm infants: Oligonephropathy and prematurity. Pediatr Nephrol 28:1791–1796PubMedCrossRefPubMedCentral
39.
Toth-Heyn P, Drukker A, Guignard JP (2000) The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 14:227–239PubMedCrossRef
40.
Osswald H, Schnermann J (2011) Methylxanthines and the kidney. Handb Exp Pharmacol 200:391–412
41.
Francart SJ, Allen MK, Stegall-Zanation J (2013) Apnea of prematurity: caffeine dose optimization. J Pediatr Pharmacol Ther 18:45–52PubMedPubMedCentral
42.
Ohlsson A, Walia R, Shah SS (2013) Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 4, CD003481PubMed
43.
Filler GM (2011) The challenges of assessing acute kidney injury in infants. Kidney Int 80:567–568PubMedCrossRef
44.
Rubin MI, Bruck E, Rapoport M (1949) Maturation of renal function in childhood; clearance studies. J Clin Invest 28:1144–1162CrossRefPubMedCentral
45.
Hayton WL (2000) Maturation and growth of renal function: dosing renally cleared drugs in children. AAPS PharmSci 2:E3PubMed
46.
Vieux R, Hascoet JM, Merdariu D, Fresson J, Guillemin F (2010) Glomerular filtration rate reference values in very preterm infants. Pediatrics 125:e1186–1192PubMedCrossRef
47.
Aperia A, Broberger O, Elinder G, Herin P, Zetterstrom R (1981) Postnatal development of renal function in pre-term and full-term infants. Acta Paediatr Scand 70:183–187PubMedCrossRef
48.
Vanpee M, Blennow M, Linne T, Herin P, Aperia A (1992) Renal function in very low birth weight infants: normal maturity reached during early childhood. J Pediatr 121:784–788PubMedCrossRef
49.
George I, Mekahli D, Rayyan M, Levtchenko E, Allegaert K (2011) Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates. Pediatr Nephrol 26:1843–1849PubMedCrossRef
50.
Kuppens M, George I, Lewi L, Levtchenko E, Allegaert K (2012) Creatinaemia at birth is equal to maternal creatinaemia at delivery: does this paradigm still hold? J Matern Fetal Neonatal Med 25:978–980PubMedCrossRef
51.
Filler G, Lepage N (2013) Cystatin C adaptation in the first month of life. Pediatr Nephrol 28:991–994PubMedCrossRef
52.
van den Anker JN, de Groot R, Broerse HM, Sauer PJ, van der Heijden BJ, Hop WC, Lindemans J (1995) Assessment of glomerular filtration rate in preterm infants by serum creatinine: comparison with inulin clearance. Pediatrics 96:1156–1158PubMed
53.
Matos P, Duarte-Silva M, Drukker A, Guignard JP (1998) Creatinine reabsorption by the newborn rabbit kidney. Pediatr Res 44:639–641PubMedCrossRef
54.
Bauer K, Versmold H (1989) Postnatal weight loss in preterm neonates less than 1,500 g is due to isotonic dehydration of the extracellular volume. Acta Paediatr Scand Suppl 360:37–42PubMedCrossRef
55.
Leslie GI, Arnold JD, Gyory AZ (1991) Postnatal changes in proximal and distal tubular sodium reabsorption in healthy very-low-birth-weight infants. Biol Neonate 60:108–113PubMedCrossRef
56.
Quigley R, Baum M (2004) Neonatal acid base balance and disturbances. Semin Perinatol 28:97–102PubMedCrossRef
57.
58.
59.
Sweet DH, Bush KT, Nigam SK (2001) The organic anion transporter family: from physiology to ontogeny and the clinic. Am J Physiol Renal Physiol 281:F197–205PubMed
60.
Sweeney DE, Vallon V, Rieg T, Wu W, Gallegos TF, Nigam SK (2011) Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney. Mol Pharmacol 80:147–154PubMedCrossRefPubMedCentral
61.
Stewart CF, Hampton EM (1987) Effect of maturation on drug disposition in pediatric patients. Clin Pharm 6:548–564PubMed
62.
Stichting Perinatale Registratie Nederland (2008) Perinatale Zorg in Nederland 2005. Stichting Perinatale Registratie Nederland, Utrecht
63.
De Cock RF, Allegaert K, Schreuder MF, Sherwin CM, de Hoog M, van den Anker JN, Danhof M, Knibbe CA (2012) Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance. Clin Pharmacokinet 51:105–117PubMedCrossRef
64.
Abdulhamid I, Wise TL, Andrews S, Biglin K, Lehr VT (2008) Elevated serum tobramycin concentrations after treatment with tobramycin inhalation in a preterm infant. Pharmacotherapy 28:939–944PubMedCrossRef
65.
Pacifici GM, Allegaert K (2012) Clinical pharmacokinetics of vancomycin in the neonate: a review. Clinics (Sao Paulo) 67:831–837CrossRef
66.
Pacifici GM (2011) Pharmacokinetics of cephalosporins in the neonate: a review. Clinics (Sao Paulo) 66:1267–1274CrossRef
67.
Fanos V, Cataldi L (1999) Antibacterial-induced nephrotoxicity in the newborn. Drug Saf 20:245–267PubMedCrossRef
68.
Langer J, Obladen M, Dame C (2008) Urinary loss of erythropoietin after intravenous versus subcutaneous epoetin-beta in preterm infants. J Pediatr 152:728–730PubMedCrossRef
69.
Yanni SB, Smith PB, Benjamin DK Jr, Augustijns PF, Thakker DR, Annaert PP (2011) Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding. Biopharm Drug Dispos 32:222–232PubMedCrossRefPubMedCentral
70.
Pullen J, Stolk LM, Degraeuwe PL, van Tiel FH, Neef C, Zimmermann LJ (2007) Protein binding of flucloxacillin in neonates. Ther Drug Monit 29:279–283PubMedCrossRef
71.
Elmas AT, Tabel Y, Elmas ON (2013) Serum cystatin C predicts acute kidney injury in preterm neonates with respiratory distress syndrome. Pediatr Nephrol 28:477–484PubMedCrossRef
72.
Sarafidis K, Tsepkentzi E, Agakidou E, Diamanti E, Taparkou A, Soubasi V, Papachristou F, Drossou V (2012) Serum and urine acute kidney injury biomarkers in asphyxiated neonates. Pediatr Nephrol 27:1575–1582PubMedCrossRef
73.
Mark LF, Solomon A, Northington FJ, Lee CK (2013) Gentamicin pharmacokinetics in neonates undergoing therapeutic hypothermia. Ther Drug Monit 35:217–222PubMedCrossRefPubMedCentral
74.
Liu X, Borooah M, Stone J, Chakkarapani E, Thoresen M (2009) Serum gentamicin concentrations in encephalopathic infants are not affected by therapeutic hypothermia. Pediatrics 124:310–315PubMedCrossRef
75.
Satas S, Hoem NO, Melby K, Porter H, Lindgren CG, Whitelaw A, Thoresen M (2000) Influence of mild hypothermia after hypoxia-ischemia on the pharmacokinetics of gentamicin in newborn pigs. Biol Neonate 77:50–57PubMedCrossRef
76.
Walker MW, Clark RH, Spitzer AR (2011) Elevation in plasma creatinine and renal failure in premature neonates without major anomalies: terminology, occurrence and factors associated with increased risk. J Perinatol 31:199–205PubMedCrossRef
77.
Kandasamy Y, Smith R, Wright IM (2013) Measuring cystatin C to determine renal function in neonates. Pediatr Crit Care Med 14:318–322PubMedCrossRef
78.
Adam MP, Polifka JE, Friedman JM (2011) Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C: Semin Med Genet 157:175–182CrossRef
79.
Schreuder MF, Bueters RR, Huigen MC, Russel FG, Masereeuw R, van den Heuvel LP (2011) Effect of drugs on renal development. Clin J Am Soc Nephrol 6:212–217PubMedCrossRef
80.
Gilbert T, Lelievre-Pegorier M, Malienou R, Meulemans A, Merlet-Benichou C (1987) Effects of prenatal and postnatal exposure to gentamicin on renal differentiation in the rat. Toxicology 43:301–313PubMedCrossRef
81.
Gilbert T, Nabarra B, Merlet-Benichou C (1988) Light- and electron-microscopic analysis of the kidney in newborn rats exposed to gentamicin in utero. Am J Pathol 130:33–43PubMedPubMedCentral
82.
Giapros VI, Papadimitriou FK, Andronikou SK (2007) Tubular disorders in low birth weight neonates after prolonged antibiotic treatment. Neonatology 91:140–144PubMedCrossRef
83.
Turcu R, Patterson MJ, Omar S (2009) Influence of sodium intake on Amphotericin B-induced nephrotoxicity among extremely premature infants. Pediatr Nephrol 24:497–505PubMedCrossRef
84.
Bagnoli F, Rossetti A, Messina G, Mori A, Casucci M, Tomasini B (2013) Treatment of patent ductus arteriosus (PDA) using ibuprofen: renal side-effects in VLBW and ELBW newborns. J Matern Fetal Neonatal Med 26:423–429PubMedCrossRef
85.
Vieux R, Fresson J, Guillemin F, Hascoet JM (2011) Perinatal drug exposure and renal function in very preterm infants. Arch Dis Child Fetal Neonatal Ed 96:F290–295PubMedCrossRef
86.
Allegaert K (2009) The impact of ibuprofen or indomethacin on renal drug clearance in neonates. J Matern Fetal Neonatal Med 22(Suppl 3):88–91PubMedCrossRef
87.
McPherson C, Gal P, Ransom JL, Carlos RQ, Dimaguila MA, Smith M, Davonzo C, Wimmer JE Jr (2010) Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability. Pediatr Cardiol 31:505–510PubMedCrossRef
88.
Brenner BM, Lawler EV, Mackenzie HS (1996) The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 49:1774–1777PubMedCrossRef
89.
Keller G, Zimmer G, Mall G, Ritz E, Amann K (2003) Nephron number in patients with primary hypertension. N Engl J Med 348:101–108PubMedCrossRef
90.
Orskov B, Christensen KB, Feldt-Rasmussen B, Strandgaard S (2012) Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease. Kidney Int 81:919–924PubMedCrossRef
91.
Keijzer-Veen MG, Finken MJ, Nauta J, Dekker FW, Hille ET, Frolich M, Wit JM, van der Heijden AJ (2005) Is blood pressure increased 19 years after intrauterine growth restriction and preterm birth? A prospective follow-up study in The Netherlands. Pediatrics 116:725–731PubMedCrossRef
92.
Keijzer-Veen MG, Schrevel M, Finken MJ, Dekker FW, Nauta J, Hille ET, Frolich M, van der Heijden BJ (2005) Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation. J Am Soc Nephrol 16:2762–2768PubMedCrossRef
93.
White SL, Perkovic V, Cass A, Chang CL, Poulter NR, Spector T, Haysom L, Craig JC, Salmi IA, Chadban SJ, Huxley RR (2009) Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis 54:248–261PubMedCrossRef
94.
Silverwood RJ, Pierce M, Hardy R, Sattar N, Whincup P, Ferro C, Savage C, Kuh D, Nitsch D (2013) Low birth weight, later renal function, and the roles of adulthood blood pressure, diabetes, and obesity in a British birth cohort. Kidney Int. doi:10.​1038/​ki.​2013.​223 PubMedPubMedCentral
95.
Silverwood RJ, Pierce M, Hardy R, Thomas C, Ferro C, Savage C, Sattar N, Kuh D, Nitsch D, National Survey of H, Development S, Data Collection T (2013) Early-life overweight trajectory and CKD in the 1946 British birth cohort study. Am J Kidney Dis 62:276–284
96.
Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW (2012) Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 8:293–300PubMedCrossRef
97.
Antonucci R, Pilloni MD, Atzori L, Fanos V (2012) Pharmaceutical research and metabolomics in the newborn. J Matern Fetal Neonatal Med 25:22–26PubMedCrossRef
98.
Hanna MH, Segar JL, Teesch LM, Kasper DC, Schaefer FS, Brophy PD (2013) Urinary metabolomic markers of aminoglycoside nephrotoxicity in newborn rats. Pediatr Res 73:585–591PubMedCrossRefPubMedCentral
99.
Hallynck T, Soep HH, Thomis J, Boelaert J, Daneels R, Fillastre JP, De Rosa F, Rubinstein E, Hatala M, Spousta J, Dettli L (1981) Prediction of creatinine clearance from serum creatinine concentration based on lean body mass. Clin Pharmacol Ther 30:414–421PubMedCrossRef
100.
Anderson BJ, Allegaert K, Van den Anker JN, Cossey V, Holford NH (2007) Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol 63:75–84PubMedCrossRefPubMedCentral
101.
Bradley JS, Sauberan JB, Ambrose PG, Bhavnani SM, Rasmussen MR, Capparelli EV (2008) Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonate. Pediatr Infect Dis J 27:794–799PubMedCrossRef
102.
Delattre IK, Musuamba FT, Jacqmin P, Taccone FS, Laterre PF, Verbeeck RK, Jacobs F, Wallemacq P (2012) Population pharmacokinetics of four beta-lactams in critically ill septic patients comedicated with amikacin. Clin Biochem 45:780–786PubMedCrossRef
Metadaten
Titel
The interplay between drugs and the kidney in premature neonates
verfasst von
Michiel F Schreuder
Ruud R G Bueters
Karel Allegaert
Publikationsdatum
01.11.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 11/2014
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-013-2651-0

Weitere Artikel der Ausgabe 11/2014

Pediatric Nephrology 11/2014 Zur Ausgabe

Original Article

Predictive value of urinary and serum biomarkers in young children with febrile urinary tract infections

Educational Review

Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases

Original Article

Phosphate homeostasis in Bartter syndrome: a case–control study

Original Article

Acute kidney injury in preterm infants admitted to a neonatal intensive care unit

Letter to the Editors

Gender differences in solitary functioning kidney: do they affect renal outcome?

Original Article

Methylmalonic acidemia: A megamitochondrial disorder affecting the kidney

Neu im Fachgebiet Pädiatrie

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Reanimation bei Kindern – besser vor Ort oder während Transport?

29.05.2024 Reanimation im Kindesalter Nachrichten

Zwar scheint es laut einer Studie aus den USA und Kanada bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

24.05.2024 Pränatale und perinatale Diagnostik Nachrichten

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise